is able to preferentially kill neoplastic cells through apoptosis. In vitro studies suggest that AP-generated reactive oxygen species (ROS) are the principal triggers of apoptosis-related signaling cascades via oxidative stress and direct interference with DNA, proteins, and other cellular components. The results of this study corroborate an ROS-mediated mechanism of cancer cell death, with apoptosis in AP-treated Mel-007 melanoma cells inhibited by pretreatment of cells with the ROS scavenger N-acetylcysteine or the caspase inhibitor zVAD-fmk. In an effort to compare apoptosis mechanisms and evaluate the in vitro-in vivo correlation for AP-induced apoptosis, Mel-007 cells were injected subcutaneously into mice to form solid tumors and were treated with AP. Histological assessment of tumors from control and AP-treated animals showed no results vary from those of other studies of AP treatment of xenograft tumors in murine models, in which a associated with translating the in vitro results to corresponding in vivo outcomes, and highlight concerns about the applicability of mechanisms established in vitro to an intrinsically dynamic in vivo environment.
I. INTRODUCTION
Melanoma is the main cause of skin cancer mortality, and Australia has the highest incidence of melanoma in the world.
1 Approximately 50% of melanomas harbor activating (V600E) mutations in the serine-threonine protein kinase B-RAF (BRAF V600E ). The BRAF gene provides instructions for making a protein involved in transmitting chemical signals from outside a cell to a cell's nucleus as part of the RAS/mitogenactivated protein kinase signaling pathway that regulates cell proliferation, migration, and apoptosis. Mutations cause the BRAF protein to be constitutively expressed, even in the absence of chemical signals, which may contribute to the growth of cancers by allowing abnormal cells to grow and divide uncontrollably. The most effective chemotherapeutic treatments for BRAF mutant melanomas are BRAF inhibitors (e.g., dabrafenib, trametinib, vemurafenib), but resistance invariably develops through BRAF truncation, upstream mutation in NRAS, or downstream mutations in MEK.
2,3 Similar to BRAF mutations, mutations in the NRAS gene lead to a continuously active NRAS protein and consequential abnormal cell proliferation and differentiation. Activated NRAS 4 Mutations in MEK genes are found in about 8% of melanomas and result in the production of the abnormally active proteins MEK1 and MEK2, which function as part of the RAS/mitogen-activated protein kinase signaling pathway; these mutations lead to faster cell division and may contribute to tumor formation. 5 An alternative therapeutic approach to the treatment of melanoma is the tumor melanoma; unfortunately, resistance to this ligand may also develop. 6, 7 Indeed, resistance to chemotherapeutic drugs is considered the greatest obstacle to the successful clinical management of cancer patients and the main contributor to the failure of chemotherapy. 8 An anticancer treatment should ideally be cytotoxic to cancer cells, have minimal effects on normal cells, and reduce the possibility of resistance. Atmospheric-pressure plasma induce apoptosis in neoplastic cells. 9, 10 Plasmas used for cancer treatment operate near room temperature in air. They create a mixture of charged and neutral reactive oxygen species (ROS) and reactive nitrogen species (RNS) that may be involved in apoptosis, [9] [10] [11] [12] Since oncogenesis involves the dysregulation of apoptosis, targeting apoptosis pathways is an attractive therapeutic approach.
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The effect of AP treatment on the signaling and checkpoint pathways that govern the cell cycle of a wide range of cancer cells has been investigated by many groups, leading apoptosis in cancer cells. 10, [16] [17] [18] [19] [20] [21] [22] of plasmas to the treated object and the treatment duration) and the plasma chemical composition, which in turn is determined by the gas composition and the mode and energy used to produce these plasmas. 23 effects-such as ion and neutral species, energetic electrons, photons, electric and death remain a subject of active debate. 10, 24, 25 Given the reports of selective apoptosis of cancer cells by plasma-activated media in vitro and in vivo, in the absence of direct contact with the plasma, [26] [27] [28] [29] [30] many researchers are of the view that AP-generated ROS and RNS are the primary drivers of plasma-induced apoptosis. However, other alone, 31 and into the nature of plasma-cell/tissue interactions more broadly. Indeed, in addition to the induction of apoptosis, in vitro plasma treatments have been shown to promote cancer cell detachment and loss, and impede cell growth, migration and invasiveness, and clonogenicity, leading to cell cycle arrest and cell senescence, mitochondrial dysfunction, downregulation of integrins, DNA damage, and modulation of the ATM/ p53 pathway. 20, 22, 25, [32] [33] [34] [35] Translation of the in vitro results to corresponding in vivo outcomes presents an the latter. Quantitative and qualitative in vitro to in vivo extrapolations to predict the trivial; concerns are often raised about the applicability of in vitro-derived chemicalin vitro to model intrinsically dynamic and complex in vivo processes. Direct AP treatment or exposure to AP-treated media in vivo have been shown to inhibit tumor growth, hinder cell proliferation, and induce cell death, leading to an overall reduction in tumor size. 30 In this study AP generated with the kINPen Plasma MED (KPM) 36, 37 was used to explore the extent to which in vitro treatment parameters can be effectively transferred into the in vivo environment, and whether the mechanisms involved in the regulation of cellular responses to atmosphericpressure plasma treatment in vitro would be observed in vivo.
II. METHODS

A. Atmospheric-Pressure Plasma Jet Device
The KPM (INP Greifswald/Neoplas Tools GmbH, Greifswald, Germany), a European regulations, generates a cold atmospheric-pressure plasma jet. The apparatus consists of a handheld unit (length, 170 mm; diameter, 20 mm), a power supply, and a gas supply unit (Fig. 1A) . The handheld unit includes a pin-type electrode (diameter, 1 mm) located in the center of a quartz capillary (inner diameter, 1.6 mm) and a grounded electrode surrounding the dielectric capillary. A high-frequency voltage (1.1 MHz) is coupled to the internal electrode. The device is operated in continuous mode. A plasma plume is generated in the pen and extends to the surrounding air outside the nozzle, and the disThe parameters of plasmas generated by KPM are well described in the literature. 12, 38 A systematic investigation of KPM-generated plasma parameters by Weltmann et al. 38 plasma temperature is within the acceptable range. The same study estimated that at this distance and a maximum input power of 6 W, the maximum recorded irradiance in the 260-to 360-nm ultraviolet range is approximately 5 W/cm 2 . 38 Fourier transform infrared analysis of biologically and chemically active species by various researchers showed the absorption features of CO 2 , CO, nitric oxide (NO), NO 2 , N 2 O, HNO 2 , and HNO 3 , whereas OH and O 3 species, which exist in the small volume of the active plasma, were not detected because of their high reactivity. [39] [40] [41] Spatial mapping of the O 3 concentration in the KPM plasma plume by Kelly et al. 42 showed peak values of 238 ppb within the vicinity of the nozzle (<25 mm), with a radius of ~5 mm. The diffusion of ambient air KPM have been discussed by Reuter et al. 43 For in vitro experiments, cells were treated with a KPM plume for 5, 10, 15, 30, and 60 seconds. For in vivo experiments, solid subcutaneous tumors were treated with a KPM plume for 8 minutes/day for 7 consecutive days. The KPM plume was positioned 5 mm from the skin (Fig. 1B) .
B. Cell Culture and Reagents
The human melanoma cell lines Mel-RM, Mel-007, and Mel-JD were a gift from Peter -
The caspase inhibitor ZVAD-fmk (G7231) and N-acetylcysteine (NAC) (a ROS scaven-
C. Cell Proliferation and Caspase 3/7 Apoptosis Assays
All cells were seeded overnight in 96-well plates at a concentration of 2 × 10 4 cells/well, treated with KPM for the indicated time periods, and incubated for 18-24 hours. Cell viability was measured using the CellTiter 96 Aqueous Non-Radioactive Cell Proliferation (MTS) Assay (G5421; Promega, Madison, WI) following the manufacturer's protocol. In was added 1-2 hours before KPM treatment. Assays were performed in triplicate. For the 
D. Animal Studies
The use of animals in these experiments was approved by the Commonwealth Scien--or depilated to apply the plasma treatment and evaluate the growth of the subcutaneous tumor. Mice were allowed to acclimatize for 1 week before the experiments. There were 3 experimental lineages (described below) with predetermined end points. Tustained with hematoxylin and eosin, then viewed using a transmitted light microscope and scored by a registered veterinary pathologist (Veterinary Pathology Diagnostic Serwere induced). A plume of KPM was held 5 mm above the sacral dorsal midline of each mouse for 5 minutes. Mice were killed 0, 24, and 48 hours after treatment. Treated and untreated skin was removed and prepared for histopathology. to establish for 7 days because this was the time required for the injected cells to adhere and grow into tumors and for tumors to develop vasculature. Then, six mice were treated with KPM for 8 minutes/day for 7 days. The treatment duration was inferred from prior in vitro experiments where desired in vitro was observed for 5-to 20-minute treatments without deleterious effects to healthy cells. The treatment protocol was similar to that used by Daeschlein et al. 44 for the treatment of subcutaneous melanoma tumors, where tumors were treated through the intact skin with a different version of the KPM device for 5 minutes daily for 5 days. The plasma plume was positioned 5 mm from the skin. A study of the luminous plasma plume produced by the KPM device showed the plasma expanding from the nozzle and reaching/maintaining 45 The other 8 mice were controls (6 with tumors and 2 with Matrigel/PBS alone) and received no KPM treatment. All mice were killed on day 24 after tumor inoculation, at which point tumors were removed and prepared for histopathology.
III. RESULTS AND DISCUSSION
Malignant melanoma is resistant to drug therapy, 2,3 and its incidence is steadily increasing at a rate of 2-5% per year. 46 In Australia, between 2006 and 2010, melanoma accounted for 14% and 23% of all cancers diagnosed among 15-to 19-and 20-to 24-year-olds. 47 and such possibility has been explored by several research groups. 26, 27, 46, 48 The outcomes of these studies and the cell death mechanisms proposed varied with the plasma device used and the treatment protocol, suggesting alterations to the cell cycle, apoptosis, and necrosis. 49 which AP preferentially induces cell death in tumor cells remain to be fully explored. One potential reason for this is the variability of the experimental procedure (plasma most studies, wherein the focus is generally placed on individual effects related to a particular application of interest rather than an attempt to correlate cell responses and intracellular dynamics. 50 Further complexities arise from in vivo studies in which the model is both highly complex and dynamic, with a high degree of inherent variability. In practical terms this means that process parameters and mechanisms derived from in vitro be accurately applied in vivo.
in vitro-derived parameters did not translate into expected in vivo outcomes, bringing to the attention of the community the potential challenges associated with in vitro-to-in vivo translation. This is particularly based to tissue and animal models. First, we examine further the mechanism of cancer cell death in vitro, and then we investigate the extent to which the killing effect, as well as the toxicity of the treatment to healthy tissues, can be replicated in vivo.
A. KPM Induces Apoptosis in Melanoma Cells In vitro
Direct and indirect exposure to plasma-generated effects has been shown to effectively and selectively kill different melanoma cancer cell lines, and a number of mechanisms have been proposed. Exposure of premetastatic and metastatic melanoma cell lines to plasma generated using surface micro-discharge resulted in irreversible cell inactivation, DNA damage, induction of sub-G 1 phase and proapoptotic events such as p53 and Rad17 phosphorylation, activation of caspase 3, and release of cytochrome c. 46 While not able to induce apoptosis, shorter durations of the same treatment led to senescence for melanoma cells treated with plasmas generated using other types of devices. 48, 51, 52 the collagen-coated surfaces and a lack of directionality in the attached cells. 53 The 2 4 , and FAK was also inhibited as a result of the plasma treatment. These proteins play notable role in malignant transformation and the attainment of metastatic phenotypes. 54, 55 Morphological changes and subsequent cell 56 Our previous studies using a custom-made plasma device showed that APs induced apoptosis in cancer cells by activating caspases via JNK/p38 kinases, inducing expression of the proapoptotic phorbol-12-myristate-13-acetate-induced protein (NOXA), and expression of the tumor suppressor protein TP73. 26, 27, 48 In this study we tested the effect of a different device, the KPM atmospheric-pressure plasma jet, on melanoma cancer cell lines. Three melanoma cell lines (Mel-RM, Mel-007, and Mel-JD) were sensitive to caspase 3/7 activity when treated with KPM, but this activity was inhibited by pretreating cells with the ROS inhibitor NAC or the caspase inhibitor zVAD (Fig. 3) . These results suggest that the apoptotic pathway induced by KPM is regulated by caspases 3/7 and is dependent on KPM-produced ROS. The susceptibility of neoplastic cells to AP and ROS may be a function of a dysregulated cell cycle and a higher cellular metabolic rate. under normal homeostatic control mechanisms.
B. In vivo Effects of KPM on Melanoma
in vitro -ly demonstrated, in vivo exposure conditions are systemically interactive and dynamic. Consequently, it is often challenging to predict the required conditions that would generate chemical concentrations and induce biological processes in the target cancer tissue (where cancer cells present as a solid tumor) that are equivalent to those at which effects were observed in an in vitro environment (where tumor cells are growing in a monolayer). As such, extensive optimization is often necessary to translate the technology from an in vitro to an in vivo in vivo outcomes based on mechanisms derived from in vitro studies and/or modeling efforts. This information transfer is further complicated by the selection of an animal model and the type of tumor cells used to induce a solid tumor, as well as inconsistencies in the methodology and approach used for in vitro studies, which is certainly the case for plasma medicine.
effect on the skin of the mice used for all experiments. Histopathology of skin samples showed no difference between KPM-treated and control skin specimens. Each specimen showed an epidermis that was 3-4 cells thick, with generalized epidermal hyperkeratosis connective tissue with a moderate cellularity above the normal subcutis and cutaneous musculature. previously been used in animal studies, would form a tumor at the injection site. Eight 
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Other biologically relevant species include O 2 , 1 O 2 , NO 2 , NO 3 , ONOO , and, more recently, Cl 2 and ClO that arise from the reaction between oxygen atoms and Cl in a solution 60 are yet to be elucidated. Furthermore, since many of the reported apoptosis studies were drawn from the experiments involving direct application of plasmas on cancer cells, it is not yet clear whether these species play an equally important role in inducing apoptosis in cells treated with plasma-activated media. 61 Yan et al. 61 recently investigated the accumulation of RNS and ROS species in plasma-activated media, demonstrating that, with a half-life of only a few microseconds, OH radicals are too reactive to penetrate deep into the media (farther than perhaps several hundred micrometers from the liquid surface). Reactive Cl 2 and ClO species are also relatively short-lived under normal cellular conditions, and as such quickly transform into a less reactive form. On the other hand, H 2 O 2 to penetrate the media and subsequently induce the biological effects in media-treated cells. 40 interactions between plasma-generated ROS and serum components. 62 In addition to species stability in media, the speed at which they can diffuse across the cellular membrane plays an important role in determining the amount of intracellular ROS. A degree of similarity between water and H 2 O 2 enables the latter to be transported across the cellular membrane by aquaporins (e.g., AQP8). 62 According to Yan et al., 61 the 2 O 2 in inducing apoptosis depends on the properties of the cell membrane and hence varies among different types of cancer cells. Within a cell, in the presence of Fe , H 2 O 2 can further form reactive OH (via the Fenton reaction), which in turn can damage DNA and other intracellular molecules. It is important to note that although H 2 O 2 may indeed be the dominant species involved in inducing apoptosis in the cancer cells subjected to plasma-treated media, 61 it is by no means the only one. Indeed, an equivalent solution of H 2 O 2 does not induce the same apoptotic effect as plasma-treated media, suggesting an important role for other plasma-generated species. NO has been shown to affect mitochondrial function through interaction with components of the electron-transport chain, and as such it not only regulates cell respiration but also increases the generation of ROS by mitochondria, activating mechanisms of cell survival or death. 63 NO can further increase the toxicity of H 2 O 2 by inhibiting H 2 O 2 degradation 64 and inactivating glutathione peroxidase 65 and other antioxidant molecules.
melanoma origin induced in mice. Tumors from control and KPM-treated animals were were 10-30% necrotic, with no observed difference between the treated and untreated groups ( Table 2) . No tissue change at the injection site was observed postmortem in
Together, these experiments showed that Mel-007 cells form a localized, vascularized melanoma when injected subcutaneously into nude mice (Fig. 4) . Injecting 1 × 10 7 cells concentrations tested. The KPM treatment regime used had no deleterious effect on the skin of the nude mice used in our study. We noted with interest that KPM treatment of the tumors in our study did not reduce tumor volume, and minimal evidence of necrosis was observed when analyzed by histopathology. This was unexpected given published tumors harvested from control and plasma-treated mice. For example, in a similar study There is one count for the whole tumor from each animal.
with plasmas generated by either an atmospheric-pressure plasma jet or dielectric barrier 44 reduction in tumor volume and weight-16 mm 3 and 42 mg for treated mice compared with 80 mm 3 and 96 mg for control mice, respectively-was observed for plasma-treated pancreatic tumors in a murine model; this was largely attributed to a high rate of ROS generation in the vicinity of the cells and ensuing apoptosis. 17 The observed accumulation of cells in the S phase of the cell cycle indicated an arrest of tumor proliferation, whereas a 3-fold increase in caspase-3-positive cells and their homogenous distribution in the 19 Reduced tumor volume positively contributed to the animals' life span, increasing it by 60% (from 9.5 to 15.0 days). 18 Although none of the aforementioned in vivo studies reported barrier discharge with microsecond pulses resulted in an increase in the subcutaneous temperature and a cutaneous skin pH reduction during the treatment, as well as a 66
It is possible the KPM plasma plume used in these experiments was too narrow to be effective. In the experiments by Keidar et al., 10 the plasma treatment was applied when the tumor diameter was <5 mm, corresponding to a volume of ~65 mm 3 , which is plasma plume is ~1 mm, the plume may cover only a very limited surface of the tumor within the treatment time, especially in the case of larger tumors. It is also possible that in vivo.
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Interestingly, with an initial melanoma tumor diameter of ~8 mm, Daeschlein et al. 44 were able to attain some positive antitumor effects using a different version of kINPen; in their experiment, however, the device was brought into direct contact with the surface of the skin. It is also possible that the chemical composition of the generated plasma species differed between our experiment and those of others in which reductions in tumor size and volume were observed." In addition to using a broader beam to cover the entire tumor, indirect treatments such as the injection of atmospheric gas plasma-treated tissue culture media into tumors may be more effective. The indirect application (by injection) of a plasmatreated medium into xenografted tumors of chronic paclitaxel-or cisplatin-resistant ovarian cancer cells in a mouse model resulted in an average inhibition of 66% (P < 0.05) and 52%, respectively. 30 The use of the ROS scavenger NAC counteracted the growth-inhibitory effects of plasma treatment, suggesting that, similar to our results for melanoma, ROS are the key contributors to plasma-induced apoptosis. It would be intuitive to expect direct plasma treatment to be even more effective because of the it is possible that, by treating media, a different range of biologically active, long-lived species may be generated (e.g., through chemical reactions between plasma-generated species and amino acids present in the media). This opens an interesting avenue for further research. 67, 68 then using KPM treatment on the tissues in the wound bed to induce apoptosis in any residual cancer cells to potentially avoid tumor regrowth and metastasis. Bringing close proximity to cancer cells may augment the apoptotic effect. Furthermore, a study by Partecke et al. 21 the top 5 layers of the tumor retaining their usual rate of proliferation. This may provide on survival rates. 10, 21, 44, 66 Following the same argument, injection of the plasma-activated media directly inside the tumor may reach the deepest layers of the tumor, 30 and hence may be better suited to the treatment of larger tumors, where higher concentrations of reactive species may need to be delivered with minimal detriment to the surrounding healthy tissues. Removal of the solid tumor before treatment, or treatment of tumors while they are relatively small, may deliver a more permanent resolution of the tumor and positively contribute to patient survival rates.
and the skin surface-as well as synergistic treatments involving anticancer drugs that are currently in use or being developed.
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IV. CONCLUSIONS
of resistance that occurs with many conventional chemotherapy protocols through the activation of apoptotic pathways in neoplastic cells. Although successful in monolayer cell culture experiments, further trials with AP are required to determine how to deliver an effective treatment through multiple layers of different tissues (e.g., skin, fat, and connective tissue) to all cells in the solid, 3-dimensional tumours that occur in vivo.
ACKNOWLEDGMENTS
the melanoma cell lines. The authors also thank Penny Bean, Dr. Vijay Vaithilingam, Organisation (CSIRO) for useful discussions and support for the experimental work and equipment. This study was supported by the CSIRO OCE postdoctoral fellowship -ogy and Advanced Materials Transformational Capability Platforms, and the Australian Research Council (DE130101550).
